Skip to content
Search

Latest Stories

CCA's 'pharmacy paradox paper' offers solutions to current paradox between ambition and reality

The Company Chemists’ Association (CCA) has published a ‘pharmacy paradox paper’ which outlines how community pharmacy can match the ambition amidst the workforce crisis.

The sector is experiencing a workforce crisis, exacerbated by NHS recruitment of community pharmacists into primary care networks.  Pharmacies are also facing a significant increase in demand on services.


CCA said, “A stretched and reduced pharmacy workforce is having to deliver more and more. This is unsustainable.”

“Unless the tension between ambition and capacity is addressed, there is a risk that community pharmacies will not only not meet their potential, but the existing offer could be compromised.”

Therefore, the association has set out solutions to resolve the current paradox between ambition and reality.

CCA's pharmacy paradox paper suggests reforms that are needed:

  • Ambitious commissioning: With the right funding, pharmacies can quickly scale up their operations to provide new care. This was seen during the Covid vaccination programme, and other pandemic services. To allow investment in people, training, and infrastructure, NHSE must commission ambitious, fully funded national services. For example, the recent announcement for a Pharmacy First service should not be limited to seven common conditions, but rapidly expanded to include all common conditions and Independent Prescribing. CCA analysis shows an ambitious Pharmacy First service in England could free up over 30 million GP appointments each year, rather than the 6 million we expect that the current government plans will free up.
  • Better use of skills mix: Whilst the time spent delivering clinical services is growing, pharmacists still spend most of their time dispensing. To increase capacity and improve access to clinical care, parts of the existing workload must be redistributed among the pharmacy team enabled through key legislative change. Changes to pharmacy supervision would allow this, but as yet there have been no changes to this foundational legislation.
  • Better use of new and advanced technologies: Better use of technology could vastly increase capacity by moving workload away from pharmacy teams. Whilst many businesses have already invested significant funds into automation, further investment relies on the commissioning of services in physical “bricks and mortar” pharmacies. Without clarity on future funded opportunities, businesses will struggle to justify more investment. Yet again promised legislation to maximise these opportunities, such as changes to Hub and Spoke requirements, and Original Pack Dispensing, have not yet materialised.

Malcolm Harrison, Chief Executive of the CCA said: "Patient demand on pharmacies has increased drastically in the last few years. We know the sector has the potential to do more, but without immediate investment it is quickly reaching breaking point. The government committed to legislative action four years ago and these changes are yet to materialise.

"Without these changes and immediate investment, the true potential of the sector will never truly be realised. It is not just the implementation of Pharmacy First at risk, other existing and essential services that could also grind to a halt".

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less